A survey by Roswell Park Comprehensive Cancer Center found that 65% of Americans are unfamiliar with CAR T-cell therapy, a personalized cancer treatment option. The therapy involves extracting and engineering immune cells to recognize and kill cancer cells, with promising results in treating blood cancers.
Scientists at Roswell Park Comprehensive Cancer Center have identified gatekeeper genes that allow prostate cancer to progress and resist treatment. The study highlights opportunities to prevent or reverse this process, offering new insights into lineage plasticity and its application in other types of cancers.
Researchers are testing a promising new vaccine against pancreatic cancer, which boasts one of cancer's poorest survival rates. The vaccine targets an abnormal variant of the ras gene, designed to stimulate an immune response against mutant ras protein.
Researchers at Roswell Park Comprehensive Cancer Center found that p53 mutation does not trigger cancer development for colorectal cancer, contrary to long-held dogma. Instead, they identified a mysterious enigma controlling cell progression to cancerous states.